Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (1): 1-5.doi: 10.19982/j.issn.1000-6621.20220462
• Special Topic • Previous Articles Next Articles
Wang Qian1, Wang Jia1, Li Yuhong2, Liu Eryong3(), Zhou Lin3(
)
Received:
2022-11-23
Online:
2023-01-10
Published:
2022-12-30
Contact:
Liu Eryong,Zhou Lin
E-mail:liuey@chinacdc.cn;zhoulin@chinacdc.cn
Supported by:
CLC Number:
Wang Qian, Wang Jia, Li Yuhong, Liu Eryong, Zhou Lin. Attach importance to childhood tuberculosis and care for children’s health[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 1-5. doi: 10.19982/j.issn.1000-6621.20220462
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220462
[1] |
田建岭, 申阿东. 儿童结核病现状. 标记免疫分析与临床, 2013, 20(12): 458-462. doi:10.11748/bjmy.issn.1006-1703.2013.06.028.
doi: 10.11748/bjmy.issn.1006-1703.2013.06.028. |
[2] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment. Tuberculosis care and support. Geneva: World Health Organization, 2022. |
[3] |
中华医学会结核病学分会儿科结核病专业委员会, 国家呼吸系统疾病临床医学研究中心, 国家呼吸系统疾病临床医学研究中心, 等. 儿科肺结核诊断专家共识.中华实用儿科杂志, 2022, 37(4):490-496. doi:10.3760/cma.j.cn101070-20220124-00089.
doi: 10.3760/cma.j.cn101070-20220124-00089. |
[4] |
卢水华. “儿童结核病零死亡率”:我们准备好了吗?. 中国防痨杂志, 2014, 36(12): 1008-1010. doi:10.3969/j.issn.1000-6621.2014.12.002.
doi: 10.3969/j.issn.1000-6621.2014.12.002. |
[5] | Lauzardo M, Nodurft-Froman M. Eliminating tuberculosis: the importance of paediatric tuberculosis surveillance. Lancet Public Health, 2019, 4(10): e485-e486.doi:10.1016/S2468-2667(19)30148-3. |
[6] |
Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis:an update. Am J Respir Crit Care Med, 2011, 183(1):88-95. doi:10.1164/rccm.201006-0974OC.
doi: 10.1164/rccm.201006-0974OC. URL |
[7] | 刘剑君, 王黎霞. 现代结核病学. 2版. 北京: 人民卫生出版社, 2022. |
[8] |
成诗明. 儿童结核病防治策略的发展与展望. 中国防痨杂志, 2014, 36(12): 1003-1007. doi:10.3969/j.issn.1000-6621.2014.12.001.
doi: 10.3969/j.issn.1000-6621.2014.12.001. |
[9] |
Dodd PJ, Yuen CM, Sismanidis C, et al. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health, 2017, 5(9):e898-e906.doi:10.1016/S2214-109X(17)30289-9.
doi: 10.1016/S2214-109X(17)30289-9. |
[10] |
Unterweger M, Götzinger F, Bogyi M, et al. Childhood tuberculosis in Vienna between 2010 and 2016. Wien Klin Wochenschr,2019, 131(15/16): 356-361. doi:10.1007/s00508-019-1510-9.
doi: 10.1007/s00508-019-1510-9. URL |
[11] |
张春华, 陈伟. 儿童结核病流行现状与经济负担研究进展. 结核与肺部疾病杂志, 2022, 3(5): 405-409. doi:10.19983/j.issn.2096-8493.20220131.
doi: 10.19983/j.issn.2096-8493.20220131. |
[12] |
Chiang SS, Khan FA, Milstein MB, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis, 2014, 14(10): 947-957. doi:10.1016/S1473-3099(14)70852-7.
doi: 10.1016/S1473-3099(14)70852-7 pmid: 25108337 |
[13] |
Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis, 2018, 22(5): 3-6. doi:10.5588/ijtld.17.0357.
doi: 10.5588/ijtld.17.0357 pmid: 29665947 |
[14] |
Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis, 2016, 16(10): 1193-1201. doi:10.1016/S1473-3099(16)30132-3.
doi: S1473-3099(16)30132-3 pmid: 27342768 |
[15] |
李亮, 端木宏谨. 1979—2000年四次全国儿童结核病流行病学抽样调查分析. 中华医学杂志, 2004, 84(20): 1678-1680. doi:10.3760/j:issn:0376-2491.2004.20.003.
doi: 10.3760/j:issn:0376-2491.2004.20.003. |
[16] |
刘二勇, 马艳, 李涛, 等. 全国14岁以下儿童肺结核疫情特征分析. 中国防痨杂志, 2014, 36(12): 1015-1020. doi:10.3969/j.issn.1000-6621.2014.12.004.
doi: 10.3969/j.issn.1000-6621.2014.12.004. |
[17] |
孙闪华, 李艳圆, 陶荔莹, 等. 2011—2020年北京市儿童肺结核报告登记及流行病学特征分析. 结核与肺部疾病杂志, 2021, 2(4): 305-310. doi:10.3969/j.issn.2096-8493.20210137.
doi: 10.3969/j.issn.2096-8493.20210137. |
[18] |
Nicol MP, Zar HJ. Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev, 2020, 36: 52-56. doi:10.1016/j.prrv.2020.05.003.
doi: 10.1016/j.prrv.2020.05.003 pmid: 32624357 |
[19] |
Jenkins HE. Global Burden of Childhood Tuberculosis. Pneumonia (Nathan), 2016, 8:24. doi:10.1186/s41479-016-0018-6.
doi: 10.1186/s41479-016-0018-6. |
[20] |
Jiao WW, Liu ZG, Han R, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis (Edinb), 2015, 95(3): 315-320. doi:10.1016/j.tube.2015.02.041.
doi: 10.1016/j.tube.2015.02.041. URL |
[21] |
李洁琼, 申阿东. 儿童耐药结核病的负担与危害. 中国防痨杂志, 2018, 40(9): 989-992. doi:10.3969/j.issn.1000-6621.2018.09.016.
doi: 10.3969/j.issn.1000-6621.2018.09.016. |
[22] |
Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol, 2013, 12(10): 999-1010. doi:10.1016/S1474-4422(13)70168-6.
doi: 10.1016/S1474-4422(13)70168-6 pmid: 23972913 |
[23] |
Wang M, Wang J, Liu X. Epidemiological Trends in the Form of Childhood Tuberculosis in a Referral Tuberculosis Hospital in Shandong, China. Biomed Res Int, 2020, 2020: 1-5. doi:10.1155/2020/6142567.
doi: 10.1155/2020/6142567. |
[24] |
Yang Y, Li X, Zhou F, et al. Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis. PLoS One, 2011, 6(6): e20343. doi:10.1371/journal.pone.0020343.
doi: 10.1371/journal.pone.0020343. |
[25] |
Zhao Y, Feng Q, Tang K, et al. The population structure of drug-resistant Mycobacterium tuberculosis clinical isolates from Sichuan in China. Infect Genet Evol, 2012, 12(4): 718-724. doi:10.1016/j.meegid.2011.09.022.
doi: 10.1016/j.meegid.2011.09.022. URL |
[26] |
Datta M, Swaminathan S. Global aspects of tuberculosis in children. Paediatr Respir Rev, 2001, 2(2): 91-96. doi:10.1053/prrv.2000.0115.
doi: 10.1053/prrv.2000.0115. pmid: 12531054 |
[27] |
李洁琼, 申阿东. 儿童结核病诊断进展及存在的问题. 中华实用儿科临床杂志, 2019, 34(5): 655-659. doi:10.3760/cma.j.issn.2095-428X.2019.09.005.
doi: 10.3760/cma.j.issn.2095-428X.2019.09.005. |
[28] |
Wu XR, Yin QQ, Jiao AX, et al. Pediatric tuberculosis at Beijing Children’s Hospital:2002—2010. Pediatrics, 2012, 130(6):e1433-1440. doi:10.1542/peds.2011-3742.
doi: 10.1542/peds.2011-3742. URL |
[29] |
Tao NN, He XC, Zhang XX, et al. Drug-Resistant Tuberculosis among Children, China, 2006—2015. Emerg Infect Dis, 2017, 23(11): 1800-1805. doi:10.3201/eid2311.170234.
doi: 10.3201/eid2311.170234. |
[30] |
刘芳, 申阿东. 儿童结核病与治疗面临的问题与思考. 中华实用儿科临床杂志, 2022, 37(4): 486-489. doi:10.3760/cma.j.cn.101070-20220124-00089.
doi: 10.3760/cma.j.cn.101070-20220124-00089. |
[31] |
Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet, 2015, 385(9979):1799-1801. doi:10.1016/S0140-6736(15)60570-0.
doi: S0140-6736(15)60570-0 pmid: 25814376 |
[32] | 赵雁林, 陈明亭. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021. |
[33] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization, 2022. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||